Thursday, May 29, 2014
Publication and contact
Mouse models of lung
squamous cell carcinoma with inactivated serine/threonine
kinase 11 (Stk11;
Mice with lung-specific
inactivation of Lkb1 and Pten could be useful as models to
evaluate therapeutic candidates for lung squamous cell carcinoma. The mice
developed malignant nodules in the lung that showed squamous characteristics
30-40 weeks after inactivation of Lkb1 and Pten. In these mice,
the histological and gene expression profile of the tumors recapitulated
multiple hallmarks of human squamous cell carcinoma. Next steps could include
evaluating the effect of various cancer therapies in the mouse model.
Published online May 29, 2014
Patent and licensing status
et al. Cancer Cell;
published online May 1, 2014;
Contact: Kwok-Kin Wong, Harvard Medical School, Boston, Mass.
Contact: Carla F. Kim, Boston Children's Hospital, Boston,
Contact: Peter S. Hammerman, Dana-Farber Cancer Institute,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]